Pfizer 2011 Annual Review | Pfizer: the world's largest research-based pharmaceutical company

Board of Directors

• 
  Dennis A. Ausiello, M.D. (2,4,5,6) Physician-in-Chief, Massachusetts General Hospital
• 
  Michael S. Brown, M.D. (4,6) Distinguished Chair, Biomedical Sciences, Regental Professor, University of Texas Southwestern Medical Center. Will retire as a Board Member effective as of the 2012 Annual Meeting.
• 
  M. Anthony Burns (1,2,4) Chairman Emeritus, Ryder System, Inc.
• 
  W. Don Cornwell (2,3,5) Founder and Retired Chairman and CEO, Granite Broadcasting Corporation
• 
  Frances D. Fergusson, Ph.D. (3,5,6) President Emeritus, Vassar College
• 
  William H. Gray III. (4,6) Chairman, Gray Global Strategies, Inc.
• 
  Helen H. Hobbs, M.D. (4,6) Investigator, Howard Hughes Medical Institute
• 
  Constance J. Horner (1,4,5) Former Assistant to the President of the United States and Director of Presidential Personnel
• 
  James M. Kilts (3,6) Founding Partner, Centerview Capital
• 
  George A. Lorch (7) Chairman Emeritus, Armstrong Holdings, Inc.
• 
  John P. Mascotte (4,5,6) Retired President and CEO, Blue Cross and Blue Shield of Kansas City, Inc.
• 
  Suzanne Nora Johnson (2,3,6) Retired Vice Chairman, The Goldman Sachs Group, Inc.
• 
  Ian C. Read (1) Chairman of the Board and CEO
• 
  Stephen W. Sanger (2, 4) Retired Chairman and CEO, General Mills
• 
  Marc Tessier-Lavigne, Ph.D. (5,6) President, Rockefeller University

• Letter to Stakeholders
• Performance
  • Financial Performance
  • Non-Financial Performance
  • 2011 Performance and
    2012 Guidance
• Stakeholder Engagement
• About This Review
• Board of Directors
• Executive Leadership Team

• (1) Executive Committee
• (2) Audit Committee
• (3) Compensation Committee
• (4) Corporate Governance Committee
• (5) Regulatory and Compliance Committee
• (6) Science and Technology Committee
• (7) Lead Independent Director

Executive Leadership Team